Analyzed by quantitative real-time PCR, nicardipine decreased MMP-9 mRNA expression in a dose-dependent manner; however, MMP-2 expression was not affected by nicardipine in 4T1, JC, and MDA-MB-231 breast cancer cells (Figures 3A–C). Here, MMP2 is linked to breast carcinoma.